DiaMedica Therapeutics DMAC
NASDAQ DMAC
$9.50 -0.16 (-1.66%)
As of: Nov 12, 2026 · 2:06 PM EST

DiaMedica Therapeutics (DMAC) Sales of Property, Plant and Equipment (2019 - 2021)

Updated

DiaMedica Therapeutics (DMAC) reported Sales of Property, Plant and Equipment of $2,000 for FY2021, down 87.5% from $16,000 in FY2020.

Analysis

DiaMedica Therapeutics (DMAC) Sales of Property, Plant and Equipment (2019 - 2021) Analysis & Trends

  • According to Business Quant data, Sales of Property, Plant and Equipment came in at $16,000 in FY2020 (+23.1%) and $13,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 DiaMedica Therapeutics 521.46 Mn 311.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 2,000.00
Dec 31, 2020 16,000.00
Dec 31, 2019 1,000.00
API Access

DiaMedica Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=DMAC&period=max&api_key=YOUR_API_KEY